Low molecular weight heparin for prevention of thromboembolic complications in cardioversion – rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin)
Crossref DOI link: https://doi.org/10.1007/s003920200019
Published Online: 2014-07-14
Published Print: 2002-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Stellbrink, C.
Hanrath, P.
Nixdorff, U.
Hofmann, T.
Lehmacher, W.
Kühle, K.
Fetsch, T.
Grewe, R.
Schmidt-Lucke, J.-A.
Text and Data Mining valid from 2002-03-01